Biodexa Pharmaceuticals Has Been Granted U.S. Patent Number 12,011,445 Titled "Prevention Of Pancreatic Cell Degeneration (For The Treatment Of Type I Diabetes)". This Patent Is Licensed From Melior Pharmaceuticals
Biodexa藥品公司獲得美國專利號12,011,445，標題爲“預防胰島細胞退化（治療1型糖尿病）”。該專利是由Melior藥品公司授權使用的。